Literature DB >> 291019

Detection of glucocorticoid receptors on Friend erythroleukemia cells.

D W Golde, N Bersch, M E Lippman, C Friend.   

Abstract

The inhibition of dimethyl sulfoxide-induced differentiation of Friend erythroleukemia cells by steroids led us to examine these cells for the presence of glucocorticoid receptors. Direct assessement of dexamethasone binding revealed high-affinity dexamethasone receptors on the untreated cells. The specific binding of [3H]dexamethasone was dose dependent. At a concentration of 10(-8) M, almost all binding sites were occupied. The mean number of binding sites per cell in two separate experiments was 8045 and 7191, respectively, and the Kd varied between 3.38 and 3.49 x 10(-9) M. Dimethyl sulfoxide treatment led to a decrease in the number of dexamethasone binding sites on the cells induced to differentiate. After 5 days of treatment, the mean number of sites per cell was reduced to 1216 and 896 in two experiments, with a Kd of 5 x 10(-9) M. Dexamethasone treatment resulted in a moderate decrease in the efficiency of colony formation within 72 hr after the cells were plated in methylcellulose. The mechanism of this inhibitory effect is unknown. However, it was also dose dependent and could be abrogated by appropriate concentrations of progesterone or 11-deoxycortisone. These results suggest that the steroid effects on growth and differentiation of the erythroleukemia cells may be mediated via glucocorticoid receptors.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 291019      PMCID: PMC383858          DOI: 10.1073/pnas.76.7.3515

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  19 in total

1.  Glucocorticoid receptors in subpopulations of childhood acute lymphocytic leukemia.

Authors:  G S Yarbro; M E Lippman; G E Johnson; B G Leventhal
Journal:  Cancer Res       Date:  1977-08       Impact factor: 12.701

2.  Surface changes in differentiating Friend erythroleukemic cells in culture.

Authors:  H Eisen; S Nasi; C P Georgopoulos; D Arndt-Jovin; W Ostertag
Journal:  Cell       Date:  1977-04       Impact factor: 41.582

3.  Inhibition of dimethyl sulfoxide-stimulated Friend cell erythrodifferentiation by hydrocortisone and other steroids.

Authors:  W Scher; D Tsuei; S Sassa; P Price; N Gabelman; C Friend
Journal:  Proc Natl Acad Sci U S A       Date:  1978-08       Impact factor: 11.205

4.  Fetal erythropoiesis in steel mutant mice. III. Defect in differentiation from BFU-E to CFU-E during early development.

Authors:  D H Chui; S K Liao; K Walker
Journal:  Blood       Date:  1978-03       Impact factor: 22.113

5.  Erythropoiesis in preleukemia.

Authors:  H P Koeffler; M J Cline; D W Golde
Journal:  Blood       Date:  1978-06       Impact factor: 22.113

6.  Cell volume changes in relation to the cell cycle of differentiating erythroleukemic cells.

Authors:  Y Gazitt; A D Deitch; P A Marks; R A Rifkind
Journal:  Exp Cell Res       Date:  1978-12       Impact factor: 3.905

7.  Control of globin gene expression by steroid hormones in differentiating Friend leukemia cells.

Authors:  S C Lo; R Aft; J Ross; G C Mueller
Journal:  Cell       Date:  1978-10       Impact factor: 41.582

8.  Induction of spectrin in erythroleukemic cells transformed by Friend virus.

Authors:  H Eisen; R Bach; R Emery
Journal:  Proc Natl Acad Sci U S A       Date:  1977-09       Impact factor: 11.205

9.  Growth hormone modulation of murine erythroleukemia cell growth in vitro.

Authors:  D W Golde; N Bersch; C H Li
Journal:  Proc Natl Acad Sci U S A       Date:  1978-07       Impact factor: 11.205

10.  Early and late volume changes during erythroid differentiation of cultured Friend leukemic cells.

Authors:  F Loritz; A Bernstein; R G Miller
Journal:  J Cell Physiol       Date:  1977-03       Impact factor: 6.384

View more
  1 in total

1.  Rapid neuromodulation by cortisol in the rat paraventricular nucleus: an in vitro study.

Authors:  Abu Zaki; R Barrett-Jolley
Journal:  Br J Pharmacol       Date:  2002-09       Impact factor: 8.739

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.